share_log

Intelligent Bio Solutions | 8-K: Current report

Intelligent Bio Solutions | 8-K: Current report

Intelligent Bio Solutions | 8-K:重大事件
美股sec公告 ·  07/24 17:05
Moomoo AI 已提取核心信息
Intelligent Bio Solutions Inc. has reported an increase in the annual base salaries of its top executives, effective April 1, 2024. The company's Chief Executive Officer, Harry Simeonidis, received a raise from USD$270,600 to USD$369,600, while Chief Financial Officer, Spiro Sakiris, saw his salary increase from USD$237,600 to USD$270,600. This decision was made following the recommendation and approval of the Compensation Committee of the Board of Directors and was announced in a Form 8-K filing with the SEC on July 23, 2024. The salaries are paid in Australian dollars and the reported figures have been converted to US dollars at the exchange rate of 1 AUD to 0.66 USD.
Intelligent Bio Solutions Inc. has reported an increase in the annual base salaries of its top executives, effective April 1, 2024. The company's Chief Executive Officer, Harry Simeonidis, received a raise from USD$270,600 to USD$369,600, while Chief Financial Officer, Spiro Sakiris, saw his salary increase from USD$237,600 to USD$270,600. This decision was made following the recommendation and approval of the Compensation Committee of the Board of Directors and was announced in a Form 8-K filing with the SEC on July 23, 2024. The salaries are paid in Australian dollars and the reported figures have been converted to US dollars at the exchange rate of 1 AUD to 0.66 USD.
智能生物解决方案公司报告称,自2024年4月1日起,其高层管理人员的年度基本工资有所增加。公司首席执行官Harry Simeonidis的薪水从美元指数270,600美元增至369,600美元,而最高财务执行官Spiro Sakiris的薪水从美元指数237,600美元增至270,600美元。该决定是在董事会薪酬委员会的建议和批准后作出,并于2024年7月23日在提交给美国证券交易委员会的8-k文件中宣布。这些薪资以澳大利亚币支付,报告数字按1澳元兑换0.66美元计算。
智能生物解决方案公司报告称,自2024年4月1日起,其高层管理人员的年度基本工资有所增加。公司首席执行官Harry Simeonidis的薪水从美元指数270,600美元增至369,600美元,而最高财务执行官Spiro Sakiris的薪水从美元指数237,600美元增至270,600美元。该决定是在董事会薪酬委员会的建议和批准后作出,并于2024年7月23日在提交给美国证券交易委员会的8-k文件中宣布。这些薪资以澳大利亚币支付,报告数字按1澳元兑换0.66美元计算。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息